Does a B-Complex Actually Work? The Honest Evidence
Educational summary — not medical advice. A B-complex is a dietary supplement; its clearest benefit is correcting a deficiency, which is a clinical question. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
The honest answer
A B-complex works mainly when it corrects a deficiency — the popular claims are weaker than the marketing. Homocysteine: lowered, but with no reduction in cardiovascular events (Cochrane, HOPE-2 — even a +unstable-angina signal, VISP). Energy: no boost unless you're deficient (Kennedy 2016). Stress/mood: genuinely mixed — some small positives, at least one null, and industry funding behind several positives. Plus two dose effects to know: the niacin flush and B6 neuropathy at high doses.
Homocysteine: the biomarker drops, the heart risk doesn't
This is the single most important honest correction about B vitamins. Folate, B12, and B6 reliably lower blood homocysteine, and homocysteine is associated with cardiovascular disease — so the pitch "lower your homocysteine to protect your heart" sounds reasonable. But the randomized trials tested exactly that chain, and it broke. Read them together:
| Study | What it tested | Finding | The honest takeaway |
|---|---|---|---|
| Martí-Carvajal 2017 (Cochrane) PMID 28816346 | Meta-analysis of homocysteine-lowering B vitamins for CV events | No reduction in heart attack (MI) or all-cause mortality | The pooled verdict: lowering homocysteine didn't prevent heart attacks or death |
| Lonn 2006 (HOPE-2) PMID 16531613 | RCT, folic acid + B6 + B12 in vascular-disease patients | Homocysteine fell; no CV composite benefit; unstable angina RR 1.24 | Not just null — a signal of more unstable angina, i.e., a possible harm |
| Toole 2004 (VISP) PMID 14762035 | RCT, high- vs low-dose B vitamins after ischemic stroke | Null on recurrent stroke/CV events despite the biomarker change | Even in stroke survivors, lowering homocysteine didn't cut recurrence |
A supporting review reaches the same place: homocysteine-lowering with B vitamins has not delivered the cardiovascular benefit its biomarker association predicted (Hankey 2018). So do not take a B-complex expecting heart protection — and note that HOPE-2's unstable-angina signal is a reason not to megadose "for your heart."
The key distinction Homocysteine is a marker, not a proven lever. B vitamins move the marker reliably, but three major trials (Cochrane, HOPE-2, VISP) show moving it doesn't move cardiovascular outcomes. "Lowers homocysteine → protects your heart" is the claim the evidence specifically refutes.
Energy: only if you're deficient
B vitamins are cofactors in the reactions that turn food into ATP, which the "B-energy" category stretches into a stimulant claim. The honest version is narrow: a genuine deficiency (B12, folate, B6, or thiamine) can cause fatigue, and correcting it can resolve that fatigue. But in people who aren't deficient, extra B-complex hasn't been shown to raise energy — a review of the mechanisms and trials found no energy benefit in the replete (Kennedy 2016). A cofactor isn't a fuel; adding more when levels are normal doesn't speed the machinery. Any lift from a B-vitamin energy drink is usually the caffeine, the sugar, or expectation.
Stress and mood: genuinely mixed (and mind the funding)
This is the claim with the most conflicting evidence, so treat confident marketing with suspicion. Some trials of a high-dose B-complex reported small improvements in stress or mood measures (Kennedy 2010), and a workplace-stress trial found a partial signal — some measures moved, others didn't (Stough 2011). But at least one well-designed trial was null on its primary stress outcome (Camfield 2013). That's a mixed literature, not a settled effect.
Two dose effects worth knowing
So who is a B-complex reasonable for?
- People correcting or preventing a deficiency — e.g., B12 in older adults, vegans, metformin users, or after bariatric surgery; folate in pregnancy. That's where the real benefit is (test, don't guess).
- Not for heart protection. Lowering homocysteine didn't cut cardiovascular events (Cochrane, HOPE-2), and HOPE-2 even showed an unstable-angina signal.
- Not as a proven energy or stress fix. No energy benefit if you're replete (Kennedy 2016); stress/mood is mixed and partly industry-funded.
- If you take one, keep the dose sane. Favor active-folate forms and a modest B6 dose — see the comparison and dosage guide.
Frequently asked questions
Does a B-complex protect the heart by lowering homocysteine?
No. It lowers the biomarker, but the trials found no reduction in heart attack or death (Martí-Carvajal 2017), no CV benefit in HOPE-2 (with an unstable-angina signal, RR 1.24), and a null stroke result (Toole 2004). Moving the marker didn't move the risk.
Does it boost energy?
Only if you're deficient. Correcting a real B12/folate/B6/thiamine deficiency can resolve that fatigue, but there's no energy benefit in people who aren't deficient (Kennedy 2016). Cofactors aren't stimulants.
Does it reduce stress or improve mood?
Mixed. Some small positives (Kennedy 2010; partial in Stough 2011), at least one null (Camfield 2013) — and several positives used the Berocca product with Bayer funding. Treat it as unsettled, not proven.
Why does niacin make me flush?
Higher B3 doses release prostaglandins that dilate skin blood vessels, causing warmth and redness within minutes (Javaid 2024). Harmless, not an allergy, dose-related — more common with high-potency products.
Related
- B-complex: what it is & who it's for
- B-complex dosage guide — what each B does + the B6 limit and a safety checker
- Active forms vs cheap & the megadose trap — and why to avoid the B6 megadose
- Best B-complex — ranked by active forms and a safe B6 dose
Sources
- Martí-Carvajal AJ, et al. "Homocysteine-lowering interventions for preventing cardiovascular events." Cochrane Database Syst Rev. 2017. PMID: 28816346
- Lonn E, et al. "Homocysteine lowering with folic acid and B vitamins in vascular disease (HOPE-2)." N Engl J Med. 2006. PMID: 16531613 (unstable angina RR 1.24).
- Toole JF, et al. "Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke (VISP)." JAMA. 2004. PMID: 14762035
- Hankey GJ. "B vitamins for stroke prevention." Stroke Vasc Neurol. 2018. PMID: 30022794 (supporting review).
- Kennedy DO, et al. "Effects of high-dose B-complex vitamins on mood and psychological strain." Psychopharmacology. 2010. PMID: 20454891 (Berocca; industry-funded).
- Stough C, et al. "Reducing occupational stress with a B-complex vitamin preparation." Hum Psychopharmacol. 2011. PMID: 21905094 (partial signal; Berocca/Bayer).
- Camfield DA, et al. "The effects of multivitamin supplementation on mood and stress." Nutrients. 2013. PMID: 24284609 (null on primary stress outcome).
- Kennedy DO. "B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review." Nutrients. 2016. PMID: 26828517 (cofactor role; no energy boost if replete).
- Javaid A, et al. "Mechanism of niacin-induced flushing." Arch Biochem Biophys. 2024. PMID: 39322100
- Schaumburg H, et al. "Sensory neuropathy from pyridoxine abuse." N Engl J Med. 1983. PMID: 6308447 (B6 neuropathy; basis for the 100 mg Upper Limit).